The article we suggest today, "World Health Organization. Target Regimen Profiles for TB Treatment", is based on the idea that TB drug research and development is moving towards developing and testing TB regimens rather than individual drugs.

SUMMARY:
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regimen characteristics corresponding to the needs of end-users. Aimed at the pharmaceutical industry, research institutions, product development partnerships, donors, non-governmental organizations (NGOs) and civil society organizations (CSOs), TRPs align targets and specifications for developers with the view of achieving shorter, less toxic, operationally feasible and cheaper regimens.

AUTHORS: The World Health Organization (WHO)